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Abstract
Introduction—Due to the increase in people who use opioids in the US, there has been a steady 
increase in injection drug use. Without access to safe syringe disposal locations, people who inject 
drugs (PWID) have few options other than improper disposal, including in public places. In 2016, 
Florida’s first legal Syringe Services Program (SSP) was established in Miami. This study aims to 
compare syringe disposal practices among PWID before and after the implementation of an SSP.
Methods—Visual inspection walkthroughs of randomly selected census blocks in the 
neighborhoods in the top quartile of narcotics-related arrests were conducted to assess improperly 
discarded syringes. Syringe location was geocoded in ArcGIS. Adult PWID pre-SSP (n=448) and 
post-SSP (n=482) implementation were recruited for a survey using respondent driven sampling in 
Miami. A Poisson regression model was used to determine the adjusted relative risk (aRR) of 
improper syringe disposal pre and post-SSP.
Results—A total of 191 syringes/1,000 blocks were found post-implementation versus 371/1,000 
blocks pre-implementation, representing a 49% decrease after SSP implementation. In the surveys, 
70% reported any improper syringe disposal post-SSP implementation versus 97% pre-SSP 
implementation. PWID in the post-implementation survey had 39% lower adjusted relative risk 
(aRR= 0.613; 95% CI=0.546, 0.689) of improper syringe disposal as compared to pre-
implementation.
Conclusions—There was a significant decrease in the number of improperly discarded syringes 
in public in Miami after the implementation of an SSP. Providing PWID with proper disposal 
venues such as an SSP could decrease public disposal in other communities.
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1 Introduction
In 2017, there were 38,739 people diagnosed with HIV in the United States (U.S.) (CDC, 
2018). Over nine percent of those diagnoses were accounted for by people who inject drugs 
(PWID) (CDC, 2018). Furthermore, injection drug use is the most common transmission 
route of hepatitis C virus (HCV) transmission in the U.S. (CDC, 2018). From 2004 to 2014, 
the increasing incidence of acute HCV correlated to the corresponding rise in injection drug 
use during this time-period (Zibbell et al., 2018). It is well established that needle sharing 
among PWID is a major risk factor for contracting both HIV and HCV (CDC, 2018; CDC, 
2018). However, needle-sticks from improperly disposed needles in public spaces rarely 
pose a viral transmission risk to community members. The annual incidence of community-
acquired needle-stick injuries in the U.S. is estimated to be 2,000 per year with an annual 
cost of $9.8 million to the healthcare system (Jason et al, 2013; Papenburg et al., 2008; 
Slinger et al., 2000; Thompson et al., 2003) and unnecessary exposure of affected 
individuals to post-exposure prophylaxis. Despite this burden, there have been very few 
studies conducted detailing the role of various public health syringe disposal interventions in 
reducing the prevalence of improperly discarded syringes (Tookes et al, 2012; Wenger et al, 
2011; Quinn et al, 2014).
Many public health interventions have been implemented in an effort to decrease the 
incidence of improper syringe disposal. These interventions include establishing Syringe 
Services Programs (SSPs) and overdose prevention sites, passing state legislation 
designating pharmacies as permissible sites for PWID to access and properly dispose of 
syringes, designating community syringe disposal sites (Riley et al., 1998), and providing 
PWID with sharps containers and education (Cleland et al., 2006; Gosden et al., 1975; 
Kinnard et al., 2014).
The current literature suggests SSPs are effective at reducing needle sharing among PWID 
and decreasing the risk of HIV and HCV infection (Abdul-Quader et al., 2013; Wodak and 
Cooney, 2006). Nationally, hospitalizations related to injection drug use have increased in 
recent years causing significant morbidity from life-threatening infectious diseases (e.g. 
endocarditis) and resulting in surging healthcare expenditures (Herzig et al, 2016; 
Feeishauer et al, 2017). Skin and soft tissue infections are common among PWID, especially 
those without adequate access to harm reduction supplies and education, and have also been 
increasing with the nationwide epidemic (Dahlman et al, 2015; Ciccarone et al, 2016); 
Dahlman et al, 2017; Smith et al, 2015). High risk injection practices are associated with 
increased risk of these preventable infections, emphasizing the need for programs that 
promote safe injection practices through education and provision of clean equipment 
(Dahlman et al, 2008; Philips et al, 2017).
By design, SSPs provide PWID access to clean syringes and proper syringe disposal. In one 
study, a city without an SSP (Miami, FL) was shown to have 8 times more improperly 
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disposed needles than a city with multiple long-established SSPs (San Francisco, CA)
(Tookes et al., 2012; Wenger et al., 2011). Furthermore, a recent study conducted in Los 
Angeles, CA, demonstrated that SSP utilization in the past 30 days was associated with 
decreased risk of improper syringe disposal whereas access to syringes from a pharmacy in 
the past 6 months was correlated with increased risk of improper syringe disposal (Quinn et 
al., 2014). In New York, NY, implementation of pharmacy sales of syringes was not 
associated with an increased number of improperly discarded syringes in public (Fuller et al, 
2002).
Miami-Dade County, Florida, continues to have the highest incidence of new HIV infections 
nationwide (2018). In response to reports of improperly discarded syringes in Miami, high 
healthcare expenditures related to injection drug use at the county safety-net hospital, 
increasing incidence of HIV, and surging number of opioid-caused deaths, the Florida 
Legislature passed the Infectious Disease Elimination Act, authorizing Florida’s first legal 
SSP in July of 2016 (Tookes et al., 2015; Tookes et al., 2012).
Prior to this investigation, to our knowledge, there have been few studies in a major U.S. city 
analyzing the changes in syringe disposal among PWID before and after the implementation 
of an SSP (Bluthenthal et al., 2007; Broadhead and Heckathorn, 1999; Doherty et al., 1997; 
Doherty et al., 2000; Quinn et al., 2014). This study compares the prevalence of improperly 
disposed syringes in public spaces and self-reported syringe disposal among PWID in 
Miami, before (2009) and after (2018) the implementation of an SSP.
2 Materials and Methods
We conducted a serial cross-sectional study, replicating the methods from Tookes et al 2012, 
to assess the differences between Miami in 2009 (pre-SSP) and Miami in 2018 (post-SSP). 
Visual inspection walkthroughs of Miami were conducted alongside structured interviews of 
PWID as part of the Center for Disease Control’s National HIV Behavioral Surveillance 
(NHBS). Data were collected June to December of 2018 and compared to the previously 
published results of Miami in 200914.
2.1 Visual Inspection Walkthroughs
Following the same methodological approach as Tookes et al 2012, visual inspection 
walkthroughs were conducted among the census block groups with the highest quartile 
number of narcotics-related arrests. Data provided by the Miami Police Department was 
mapped using ArcGIS Software (version 10.2; Redlands, CA). From the top quartile of 
census block groups, we randomly selected 775 census blocks for visual inspection 
walkthroughs. All four sides of each census block were inspected for improperly discarded 
syringes. Visual inspections were conducted in all publicly accessible areas, including 
sidewalks, alleys, parks and parking lots. All syringes that were found during the 
walkthroughs were photographed and geocoded via mobile phone in ArcGIS. Walkthroughs 
occurred from July to December of 2009 and August to December of 2018.
Levine et al. Page 3
Drug Alcohol Depend. Author manuscript; available in PMC 2020 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
2.2 Quantitative Surveys of PWID
To examine the differences in syringe disposal practices among PWID, we conducted 
surveys of PWID in Miami at two time points pre and post SSP implementation (N=448 in 
2009 and N=482 in 2018). As part of NHBS, respondent-driven sampling (RDS) was used to 
recruit participants. RDS has been shown to be an effective strategy for the recruitment of 
hidden populations involved in illegal behaviors (Lansky et al., 2007; Magnani et al., 2005; 
Malekinejad et al., 2008; Malekinejad et al., 2011). Eligibility criteria included: (1) age 18 
years or older; (2) injection of illicit drugs within the previous 12 months; and (3) informed 
consent. All data were collected via face-to-face interview and recorded electronically on a 
handheld assisted personal interviewing tablet computer. The interview application was 
developed using Questionnaire Development System software (QDS™ Version 2.6.1, NOVA 
Research Company, Bethesda, Maryland).
2.3 Ethics Statement
The visual inspection walkthroughs were exempt from human subjects research. The 
quantitative surveys were approved by the Institutional Review Boards at the University of 
Miami (IRB#20170527) and the Florida Department of Health (IRB#2017-20-FDOH).
2.4 Measures
To compare results pre and post SSP implementation, we used the same syringe disposal 
measures that had been developed in Miami in 2009 (Tookes et al 2012). This included 
asking how many syringes in the past 30 days had been disposed of (a) in a public place, (b) 
by selling or giving away, (c) in the trash, (d) at an SSP, (e) at a hospital/clinic, (f) at a 
pharmacy, (g) in a sharps container, or (h) other place. The main outcome variable was 
improper syringe disposal, which is defined as having disposed of a syringe in a public 
place, by selling them or giving them away, by putting them in the trash at home or another’s 
home, in the sewer, or by flushing.
The outcome variable combined the counts of the improper methods of syringe disposal by 
summing them. Then that variable was dichotomized into no improper syringe disposal (no 
improper disposal methods) and improper disposal (>1 improper disposal method reported).
2.5 Statistical Analyses
2.5.1. Visual Inspection Walkthroughs—The number of syringes found in Miami in 
2018 was standardized per 1,000 census blocks in the sample. We also standardized the 
number of syringes per 1,000 people living in the census blocks inspected.
2.5.2 Quantitative Survey of PWID—We compared demographic and individual 
syringe disposal location variables by pre and post-SSP implementation samples using chi-
squared tests. Because the two samples were 9 years apart, it is not possible to use RDS-
specific statistical methods (RDSAT). As such, the samples were not weighted to adjust for 
interdependence of study participants. A multivariable Poisson regression model with robust 
standard errors was used to assess the difference in self-reported improper disposal of 
syringes in 2009 and 2018, both unadjusted and adjusting for gender, race/ethnicity, ever 
HIV-positive, and currently homeless. Analyses were performed using SAS statistical 
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software (Version 9.4; SAS Institute, Cary, NC). All tests were performed at a significance 
level of 0.05, and unadjusted (RR), adjusted relative risk ratios (aRR) and 95% confidence 
intervals (CI) were reported.
3 Results
3.1 Visual Inspection Walkthroughs and Syringe Density
There were a total of 149 syringes (191 per 1,000 census blocks) found in Miami in 2018 
compared to 328 syringes (371 per 1,000 census blocks) found in Miami in 2009. This 
represents a 49% decrease in syringes found in public areas after the implementation of an 
SSP. The number of syringes found per 1,000 people decreased from 4.9 in 2009 to 1.2 in 
2018, representing a 75% decrease post-SSP. The locations of the syringes that were found 
in Miami in 2009 and 2018 are presented in Figure 1. Each dot represents the location of an 
encountered syringe and can represent many syringes found within the census block.
3.2 Quantitative Surveys
The demographic and syringe disposal practices in 2009 and 2018 are presented in Table 1. 
The sample in 2018 was significantly more likely to be non-Hispanic White (29% vs. 23%, 
p=0.004), younger (49% younger than 40 vs. 28%, p<0.001) and to report current 
homelessness (84% vs. 50%, p<0.001).
In bivariate analysis, PWID in 2018 were significantly less likely to report disposal of 
syringes in a public place (49.1% vs. 68.7%, p<0.001) and in the trash (31.3% vs. 66.2%, 
p<0.001) compared to PWID in 2009. After the establishment of the SSP, 38.6% PWID 
surveyed in 2018 reported syringe disposal at the SSP. Additionally, in 2018, PWID were 
significantly more likely to dispose of syringes in a sharps container (15.4% vs. 3.8%, 
p<0.001) and sell/give away syringes (23.3% vs. 12.6%, p<0.001) than in 2009. Overall, 
PWID in 2018 were significantly less likely to report any improper disposal of syringes 
(69.5% vs. 96.6%, p<0.001) than in 2009.
Of the total reported syringes disposed in the past 30 days, in 2018, 25.3% (7,960 of 31,412) 
were improperly disposed of compared to 94.9% (9,845 of 10,379) in 2009. In 2018, 17,914 
(57%) and 5,029 (16%) syringes were disposed of in a SSP or sharps container, respectively, 
compared to 0 (0%) and 334 (3.2%) in 2009 (Table 2).
In the multivariable Poisson regression (Table 3), after adjusting for gender, age, race/
ethnicity, homelessness, and HIV-positive status, PWID in the post-implementation survey 
had 29.5% lower non-adjusted (RR= 0.705; 95% confidence interval [CI]=0.659, 0.755), and 
39% lower adjusted (aRR= 0.613; 95% CI=0.546, 0.689) relative risk of improper syringe 
disposal as compared to PWID in the pre-implementation survey. The regression model also 
revealed that those reporting current homelessness had increased adjusted relative risk of 
improper syringe disposal (aRR=1.589, 95% CI: 1.400, 1.803).
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4 Discussion
This study provides comparative data assessing syringe disposal in a city before and after the 
implementation of an SSP both through visual inspection walkthroughs and a quantitative 
survey. There were almost half of the number of syringes found discarded publicly in Miami 
after SSP implementation, at a time when there is a national Public Health Emergency due to 
the opioid overdose crisis. Importantly, the quantitative survey corroborated these findings, 
with PWID in 2018 significantly less likely to report that they improperly disposed of 
syringes. Public awareness of the nationwide opioid overdose crisis and acceptance of opioid 
use disorder as a disease could have contributed to better syringe disposal practices, but the 
decrease in improperly discarded syringes in public despite increased opioid use suggests 
the importance of the SSP in providing a venue for proper syringe disposal.
While only 38.6% of respondents in 2018 reported having used the SSP, 57% of syringes 
disposed by all respondents in the prior 30 days were disposed at the SSP. This suggests that 
the SSP provides safe disposal for not just the PWID who use the program. PWID who go to 
SSPs often exchange syringes for PWID who do not go to SSPs, thus broadening the reach 
of SSPs (Lorvick et al., 2006). Additionally, the increase in syringe disposal in sharps 
containers is likely the result of widespread distribution of sharps containers at the SSP, 
suggesting that up to 73% percent of syringes were properly disposed in 2018 as a result of 
the SSP. Increasing the reach of the SSP through concerted mobile outreach in the areas 
identified with publicly discarded syringes should be prioritized in order to increase the 
number of syringes in circulation and simultaneously provide a venue for proper disposal 
(Iyengar et al., 2019; Kaplan and Heimer, 1994). This increased access to syringes has been 
shown to decrease syringe sharing and HIV infection among PWID (Bluthenthal et al., 
2007). Importantly, visual inspection of blocks in Miami showed that there were 49% fewer 
improperly disposed syringes in public post-SSP implementation, despite the SSP’s 
distribution of 149,989 syringes in 2018. These results support the findings of Tookes et al 
(2012) that SSPs are a significant means of collecting of used syringes and do not increase 
the number of publicly discarded syringes.
Several potential limitations should be noted when interpreting the results of this study. First, 
the visual inspection study may have undercounted the number of publicly discarded 
syringes in 2018 because there may have been an increase in public works cleanup due to 
gentrification of parts of Miami. However, the visual inspection walkthroughs were not 
conducted in the same blocks during 2009 and 2018, but in the areas most affected by drug 
use at each point in time as reflected in Miami Police Department data. Furthermore, the 
survey data of PWID corroborated our visual inspection findings. Second, these findings 
may not generalize to all areas of the city or to other cities. Third, the results of the 
quantitative survey may have been impacted by social desirability or recall bias. However, it 
is important to note that these surveys were conducted as part of a Florida Department of 
Health and Centers for Disease Control surveillance, independent of the SSP or its staff. We 
conducted both quantitative surveys and walkthrough inspections in order to address the 
limitations of each individual study design.
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5 Conclusion
There was a significant decrease in the number of improperly discarded syringes 
encountered through visual inspection of in Miami after the implementation of the SSP, a 
finding that was corroborated by quantitative surveys of PWID. Providing PWID proper 
disposal venues such as an SSP could decrease public syringe disposal in other communities 
where they are implemented, while also reducing syringe sharing and its attendant risks for 
HIV and viral hepatitis transmission.
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Figure 1. Locations of Publicly Discarded Syringes
1A. Locations of found syringes in Miami, FL Pre-SSP (2009)
1B. Locations of found syringes in Miami, FL Post-SSP (2018)
Levine et al. Page 10
Drug Alcohol Depend. Author manuscript; available in PMC 2020 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Levine et al. Page 11
Table 1
Demographic Characteristics of People Who Inject Drugs in Miami 2009 and 2018 and Self-reported Syringe 
Disposal Locations in the Past 30 days
Variable
Miami 2009
(n=448)
Miami 2018
(n=482) p-value
Biological Sex 0.766
Male 79% 77%
Female 21% 23%
Intersex 0% 0%
Race/ethnicity 0.004
White (Non-Hispanic) 23% 29%
Black (Non-Hispanic) 36% 29%
Hispanic 40% 39%
Native American 1% 2%
Asian or Pacific Islander 1% 1%
Multiple Races/Other 0% 1%
Age (years) <0.001
18–29 8% 17%
30–39 20% 32%
40–49 31% 25%
50+ 41% 26%
Currently homeless 50% 84% <0.001
HIV-positive (self- report) 10% 11% 0.788
Syringe Disposal Locations
Public place 68.7% 49.1% <0.001
Selling/giving away 12.6% 23.3% <0.001
Trash 66.2% 31.3% <0.001
SSP 0% 38.6% <0.001
Hospital or clinic 1.6% 1.9% 0.802
Pharmacy 0% 0% -
Sharps container 3.8% 15.4% <0.001
Other Location 6.5% 8.3% 0.293
Any improper disposal 96.6% 69.5% <0.001
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Table 2
Number of Syringes Disposed in the Past 30 days as reported by People Who Inject Drugs in Miami Pre 
(2008) and Post (2018) implementation of SSP
Disposal Location Pre-SSP (%) Post-SSP (%)
Public Place 4,689 (45.2) 4,095 (13.0)
Selling/giving away 675 (6.5) 1,301 (4.1)
Trash 4,004 (38.6) 2,356 (7.5)
Syringe Service Program 0 (0.0) 17,914 (57.0)
Hospital or clinic 200 (1.9) 128 (0.4)
Pharmacy 0 (0.0) 8 (0.03)
Sharps container 334 (3.2) 5,029 (16.0)
Sewer/manhole 234 (2.2) 0 (0)
Flush down the toilet 163 (1.6) 208 (0.7)
Other 80 (0.8) 373 (1.2)
Total syringes improperly disposed 9,845 (94.9) 7,960 (25.3)
Total syringes disposed 10,379 31,412
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Table 3
Self-reported Improper Disposal of Syringes by People Who Inject Drugs in Miami (N=930)
Variable RR 95% CI aRR 95% CI
Miami Pre vs Post-SSP 0.705* (0.66 – 0.755) 0.61* (0.545 – 0.69)
Male (vs Female) 1.03 (0.95 – 1.11) 1.15 (0.985 - 1.34)
Age (years) 1.00 (1.00 – 1.01) 0.995 (0.99 - 1.00)
Race/Ethnicity
  White (vs Black) 0.88* (0.81 – 0.96) 0.89 (0.76 - 1.05)
  Other (vs Black) 0.78 (0.60 – 1.01) 0.83 (0.55 - 1.25)
  Hispanic (vs Black) 0.95 (0.89 – 1.02) 1.03 (0.90 - 1.17)
Homeless 1.04 (0.975 – 1.11) 1.59* (1.40-1.80)
HIV Positive 0.91 (0.815 – 1.02) 0.935 (0.78 - 1.125)
*
significant at p < 0.05
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